Triple-negative breast cancer: Early assessment with 18F-FDG PET/CT during neoadjuvant chemotherapy identifies patients who are unlikely to achieve a pathological complete response

被引:0
|
作者
Groheux, David [1 ]
Hindie, Elif [1 ]
Giacchetti, Sylvie [2 ]
Delord, Marc [3 ]
Hamy, Anne-Sophie [2 ]
De-roquancourt, Anne [4 ]
Vercellino, Laetitia [1 ]
Berenger, Nathalie [1 ]
Marty, Michel [2 ]
Espie, Marc [2 ]
机构
[1] St Louis Hosp, Dept Nucl Med, Paris, France
[2] St Louis Hosp, Breast Dis Unit, Paris, France
[3] Inst Univ Hematol, Plateforme Bioinformat Biostat, Paris, France
[4] St Louis Hosp, Dept Pathol, Paris, France
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
366
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Integrated 18F-FDG PET/MRI in breast cancer: early prediction of response to neoadjuvant chemotherapy
    Nariya Cho
    Seock-Ah Im
    Gi Jeong Cheon
    In-Ae Park
    Kyung-Hun Lee
    Tae-Yong Kim
    Young Seon Kim
    Bo Ra Kwon
    Jung Min Lee
    Hoon Young Suh
    Koung Jin Suh
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 328 - 339
  • [42] Integrated 18F-FDG PET/MRI in breast cancer: early prediction of response to neoadjuvant chemotherapy
    Cho, Nariya
    Im, Seock-Ah
    Cheon, Gi Jeong
    Park, In-Ae
    Lee, Kyung-Hun
    Kim, Tae-Yong
    Kim, Young Seon
    Kwon, Bo Ra
    Lee, Jung Min
    Suh, Hoon Young
    Suh, Koung Jin
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (03) : 328 - 339
  • [43] The prediction of pathologic response to neoadjuvant chemotherapy in breast cancer patients: ultrasonography versus 18F-FDG PET/CT
    Cakmak, G. Karadeniz
    Emre, A. U.
    Uslu, R.
    Engin, H.
    Bahadir, B.
    Bakkal, B. H.
    BREAST, 2019, 44 : S73 - S73
  • [44] Prediction of response to neoadjuvant chemotherapy in patients with breast cancer using texture analysis of 18F-FDG PET/CT
    Ha, Seunggyun
    Lee, Ho-Young
    Kim, Sang Eun
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [45] Multiparametric 18F-FDG PET/MRI-Based Radiomics for Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
    Umutlu, Lale
    Kirchner, Julian
    Bruckmann, Nils-Martin
    Morawitz, Janna
    Antoch, Gerald
    Ting, Saskia
    Bittner, Ann-Kathrin
    Hoffmann, Oliver
    Haeberle, Lena
    Ruckhaeberle, Eugen
    Catalano, Onofrio Antonio
    Chodyla, Michal
    Grueneisen, Johannes
    Quick, Harald H.
    Fendler, Wolfgang P.
    Rischpler, Christoph
    Herrmann, Ken
    Gibbs, Peter
    Pinker, Katja
    CANCERS, 2022, 14 (07)
  • [46] Correlation between 18F-FDG uptake on PET/CT and prognostic factors in triple-negative breast cancer
    Hye Ryoung Koo
    Jeong Seon Park
    Keon Wook Kang
    Wonshik Han
    In Ae Park
    Woo Kyung Moon
    European Radiology, 2015, 25 : 3314 - 3321
  • [47] Negative Predictive Value Of 18F-FDG PET/CT In The Axillary Response to Neoadjuvant Chemotherapy In Patients Diagnosed Of Locally Advanced Breast Cancer
    Lara Martinez, M.
    Lopez Acosta, M.
    Diaz Silvan, A.
    Vilahomat Hernandez, O.
    Cabello Garcia, D.
    Una Gorospe, J.
    Allende Riera, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S550 - S551
  • [48] Correlation between 18F-FDG uptake on PET/CT and prognostic factors in triple-negative breast cancer
    Koo, Hye Ryoung
    Park, Jeong Seon
    Kang, Keon Wook
    Han, Wonshik
    Park, In Ae
    Moon, Woo Kyung
    EUROPEAN RADIOLOGY, 2015, 25 (11) : 3314 - 3321
  • [49] Predictors of distant metastasis in patients with triple negative breast cancer who failed to achieve a pathological complete response after neoadjuvant chemotherapy
    Tricarico, C. J.
    Gabani, P.
    Weiner, A. A.
    Ochoa, L. L.
    Thomas, M. A.
    Zoberi, I.
    CANCER RESEARCH, 2019, 79 (04)
  • [50] Early prediction of pathological complete response in luminal B type neoadjuvant chemotherapy-treated breast cancer patients: comparison between interim 18F-FDG PET/CT and MRI
    Pahk, Kisoo
    Kim, Sungeun
    Choe, Jae Gol
    NUCLEAR MEDICINE COMMUNICATIONS, 2015, 36 (09) : 887 - 891